Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octafibrin for Congenital Fibrinogen Deficiency
NCT02267226Phase 3Completed
- Sponsor
- Octapharma
- Start
- Sep 2014
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of Fibrinogen human in congenital fibrinogen deficiency (CFD), sponsored by Octapharma. Started Sep 2014; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital fibrinogen deficiency (CFD)
Beyond the preview
Go deeper on NCT02267226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02267226.